Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET

Anthony K P Jones, Hiroshi Watabe, Vincent Joseph Cunningham, Terry Jones

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.
Original languageEnglish
Pages (from-to)479-485
Number of pages7
JournalEuropean Journal of Pain
Volume8
Issue number5
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Diprenorphine
Opioid Receptors
Neuralgia
Pain
Gyrus Cinguli
Opiate Alkaloids
Pharmacology
Nociceptors
Parietal Lobe
Thalamus
Analgesia
Central Nervous System
Stroke
Neurons

Keywords

  • aged
  • analgesics
  • opioid receptor
  • cerebral cortex
  • diprenorphine
  • down-regulation
  • drug resistance
  • female
  • humans
  • male
  • middle aged
  • neurological models
  • neural pathways
  • opioid peptides
  • intractable pain
  • positron emission tomography
  • predictive value of tests
  • radioligand assay
  • central deafferentation
  • stroke
  • thalamus
  • pain
  • brain
  • post-stroke pain
  • spinal cord
  • mechanisms

Cite this

Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET. / Jones, Anthony K P; Watabe, Hiroshi; Cunningham, Vincent Joseph; Jones, Terry.

In: European Journal of Pain, Vol. 8, No. 5, 10.2004, p. 479-485.

Research output: Contribution to journalArticle

Jones, Anthony K P ; Watabe, Hiroshi ; Cunningham, Vincent Joseph ; Jones, Terry. / Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET. In: European Journal of Pain. 2004 ; Vol. 8, No. 5. pp. 479-485.
@article{66726182c7004c6387dcf156a375cb82,
title = "Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET",
abstract = "Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.",
keywords = "aged, analgesics, opioid receptor, cerebral cortex, diprenorphine, down-regulation, drug resistance, female, humans, male, middle aged, neurological models, neural pathways, opioid peptides, intractable pain, positron emission tomography, predictive value of tests, radioligand assay, central deafferentation, stroke, thalamus, pain, brain, post-stroke pain, spinal cord, mechanisms",
author = "Jones, {Anthony K P} and Hiroshi Watabe and Cunningham, {Vincent Joseph} and Terry Jones",
year = "2004",
month = "10",
doi = "10.1016/j.ejpain.2003.11.017",
language = "English",
volume = "8",
pages = "479--485",
journal = "European Journal of Pain",
issn = "1090-3801",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET

AU - Jones, Anthony K P

AU - Watabe, Hiroshi

AU - Cunningham, Vincent Joseph

AU - Jones, Terry

PY - 2004/10

Y1 - 2004/10

N2 - Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.

AB - Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.

KW - aged

KW - analgesics

KW - opioid receptor

KW - cerebral cortex

KW - diprenorphine

KW - down-regulation

KW - drug resistance

KW - female

KW - humans

KW - male

KW - middle aged

KW - neurological models

KW - neural pathways

KW - opioid peptides

KW - intractable pain

KW - positron emission tomography

KW - predictive value of tests

KW - radioligand assay

KW - central deafferentation

KW - stroke

KW - thalamus

KW - pain

KW - brain

KW - post-stroke pain

KW - spinal cord

KW - mechanisms

U2 - 10.1016/j.ejpain.2003.11.017

DO - 10.1016/j.ejpain.2003.11.017

M3 - Article

VL - 8

SP - 479

EP - 485

JO - European Journal of Pain

JF - European Journal of Pain

SN - 1090-3801

IS - 5

ER -